Skip to main content
. Author manuscript; available in PMC: 2014 Jan 4.
Published in final edited form as: J Med Chem. 2013 Jun 26;56(13):10.1021/jm400510u. doi: 10.1021/jm400510u

Table 2.

Affinities of compounds 23-31 and 33 for Rat nAChR Subtypes Defined by Competition for [3H]Epibatidine Binding

Compd. Ki (nM) a
α2β2 α2β4 α3β2 α3β4 α4β2 α4β2* b α4β4
23 NA NA NA NA 2176 NA NA
24 0.5±0.1 612 17.3±5.3 NA 0.4±0.1 1.1±0.2 161
25 18.1±2.3 >104 2534 NA 38.8±7 221 >104
26 0.2 129.5 21±5.7 NA 0.3 0.5±0.1 584.8
27 167.9 NA NA NA 49.5±8.9 173.7 NA
28 43.8±10.7 NA 2094 NA 28.5±5.6 193.8 NA
29 12.9±1.7 9959 472.5 NA 21.7±6.6 86.6±15.3 9475
30 0.04 50.8±10.5 0.8±0.2 2074 0.05 0.2 30±4.3
31 6.1±0.6 NA 191.5 NA 90.9±27 40.7±5.3 NA
33 3.5±0.5 546.6 137.3 NA 3.3±1 15.7±2.8 234.1
4 c 0.1 236 2.4 NA 0.1 0.3 50.2
nicotine d 5.5 70 29 260 4.9 9.8 23
saz-A e 0.087 210 0.38 1900 0.062 0.17 52
a

See Experimental Section. SEM values are not provided for Ki values > 100 nM.

b

α4β2*, prepared from rat forebrain.

c

Ki values for compound 4 are obtained from Reference 15.

d

Ki values for nicotine are taken from the PDSP Assay Protocol Book (http://pdsp.med.unc.edu/).

e

Ki values for sazetidine-A were obtained from the literature.22

NA: not active, defined as < 50% binding in the primary assay at 10 μM.